Rainbow Childrens Medicare DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.78×	0.79×	0.74×	0.74×	0.75×
	0.89×	0.91×	0.94×	0.93×	0.92×
	22.9%	23.1%	23.2%	24.4%	26.1%
	0.66×	0.66×	0.67×	0.66×	0.76×
	1.67×	1.67×	1.61×	1.72×	1.67×
	17.6%	18.2%	17.4%	19.1%	22.9%
	17.9%	17.9%	17.9%	18.7%	25.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RAINBOW₹1,196.80

Rainbow Childrens Medicare Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS KIMS POLYMED PFIZER ONESOURCE JUBLPHARMA VIJAYAMcap ₹12,155 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.74	0.74	0.79	0.78
Interest Burden (Pretax/EBIT) ×	0.92	0.93	0.94	0.91	0.89
EBIT Margin %	26.08	24.43	23.18	23.11	22.89
Asset Turnover ×	0.76	0.66	0.67	0.66	0.66
Financial Leverage (Assets/Equity) ×	1.67	1.72	1.61	1.67	1.67
ROE (5-step product, year-end total equity) %	22.94	19.06	17.40	18.20	17.56
ROE (owners' profit / average owners' equity) %	25.36	18.72	17.85	17.86	17.86

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.